iBio Inc [NASDAQ: IBIO] stock went on an upward path that rose over 0.65% on Thursday, amounting to a one-week price increase of more than 22.05%.
Over the last 12 months, IBIO stock dropped by -36.73%. The one-year iBio Inc stock forecast points to a potential upside of 51.56. The average equity rating for IBIO stock is currently 1.00, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $31.39 million, with 19.35 million shares outstanding and 19.12 million shares in the current float. Compared to the average trading volume of 3.03M shares, IBIO stock reached a trading volume of 15054592 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on iBio Inc [IBIO]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for IBIO shares is $3.20 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on IBIO stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Oppenheimer have made an estimate for iBio Inc shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on October 21, 2025. While these analysts kept the previous recommendation, Leerink Partners raised their target price to Outperform. The new note on the price target was released on October 17, 2025, representing the official price target for iBio Inc stock. Previously, the target price had yet another raise to $5, while Chardan Capital Markets analysts kept a Buy rating on IBIO stock.
The Price to Book ratio for the last quarter was 2.02, with the Price to Cash per share for the same quarter was set at 0.42.
IBIO Stock Performance Analysis:
iBio Inc [IBIO] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 22.05. With this latest performance, IBIO shares gained by 88.15% in over the last four-week period, additionally plugging by 50.49% over the last 6 months – not to mention a drop of -36.73% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for IBIO stock in for the last two-week period is set at 78.14, with the RSI for the last a single of trading hit 0.2267, and the three-weeks RSI is set at 0.1542 for iBio Inc [IBIO]. The present Moving Average for the last 50 days of trading for this stock 0.9201, while it was recorded at 1.3940 for the last single week of trading, and 1.7585 for the last 200 days.
Insight into iBio Inc Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and iBio Inc [IBIO] shares currently have an operating margin of -4650.50% and a Gross Margin at -181.50%. iBio Inc’s Net Margin is presently recorded at -4594.25%.
iBio Inc (IBIO) Capital Structure & Debt Analysis
According to recent financial data for iBio Inc. ( IBIO), the Return on Equity (ROE) stands at -101.52%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -70.79%, reflecting the company’s efficiency in generating profits from its assets. Additionally, iBio Inc’s Return on Invested Capital (ROIC) is -107.60%, showcasing its effectiveness in deploying capital for earnings.
iBio Inc (IBIO) Efficiency & Liquidity Metrics
Based on iBio Inc’s (IBIO) latest financial statements, the Debt-to-Equity Ratio is 0.24%, indicating its reliance on debt financing relative to shareholder equity.
iBio Inc (IBIO) Efficiency & Liquidity Metrics
From an operational efficiency perspective, iBio Inc. (IBIO) effectively leverages its workforce, generating an average of -$919000.0 per employee. The company’s liquidity position is robust, with a Current Ratio of 1.59% and a Quick Ratio of 1.59%, indicating strong ability to cover short-term liabilities.
IBIO Stock EPS
With the latest financial reports released by the company, iBio Inc posted -0.46/share EPS, while the average EPS was predicted by analysts to be reported at -0.46/share. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for IBIO. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for iBio Inc go to 39.90%.
iBio Inc [IBIO] Institutonal Ownership Details
There are presently around $16.54%, or 17.22%% of IBIO stock, in the hands of institutional investors. The top three institutional holders of IBIO stocks are: LYNX1 CAPITAL MANAGEMENT LP with ownership of 0.6 million shares, which is approximately 6.9576%. IKARIAN CAPITAL, LLC, holding 0.6 million shares of the stock with an approximate value of $$1.27 million in IBIO stocks shares; and IKARIAN CAPITAL, LLC, currently with $$1.2 million in IBIO stock with ownership which is approximately 6.6097%.
